Cargando…

The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review

Coronavirus disease 2019 (COVID-19)-associated coagulopathy (CAC), characterized by hypercoagulability and an increased risk of thrombotic complications, is an important consideration in the management of patients with COVID-19. As COVID-19 is a new disease, no standard of care for the diagnosis or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartmann, Jan, Ergang, Alexis, Mason, Dan, Dias, Joao D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911186/ https://www.ncbi.nlm.nih.gov/pubmed/33530346 http://dx.doi.org/10.3390/diagnostics11020172

Ejemplares similares

TEG® and RapidTEG® are unreliable for detecting warfarin-coagulopathy: a prospective cohort study
por: Dunham, C Michael, et al.
Publicado: (2014)

TEG(®), Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy
por: Laubscher, Gert Jacobus, et al.
Publicado: (2021)

Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review
por: Da Luz, Luis Teodoro, et al.
Publicado: (2014)

Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
por: Walsh, Mark, et al.
Publicado: (2016)

A comparison between the TEG 6s and TEG 5000 analyzers to assess coagulation in trauma patients
por: Neal, Matthew D., et al.
Publicado: (2020)

The Role of TEG and ROTEM in Damage Control Resuscitation
por: Brill, Jason B., et al.
Publicado: (2021)

“TEG” talks: technology worth spreading?
por: Selby, Rita
Publicado: (2023)

Coagulation support algorithm with rapid TEG and functional fibrinogen TEG in critical bleeding: more results and less time
por: Blasio, E De, et al.
Publicado: (2015)

Assessment of agreement and interchangeability between the TEG5000 and TEG6S thromboelastography haemostasis analysers: a prospective validation study
por: Lloyd-Donald, P., et al.
Publicado: (2019)

Coagulopathy in patients with COVID-19: a systematic review and meta-analysis
por: Zhang, Xiaolin, et al.
Publicado: (2020)

Is viscoelastic coagulation monitoring with ROTEM or TEG validated?
por: Solomon, Cristina, et al.
Publicado: (2016)

The Value of Thromboelastography (TEG) in COVID-19 Critical Illness as Illustrated by a Case Series
por: Wang, Janice, et al.
Publicado: (2022)

The role of point of care thromboelastography (TEG) and thromboelastometry (ROTEM) in management of Primary postpartum haemorrhage: A meta-analysis and systematic review
por: Khanna, Puneet, et al.
Publicado: (2023)

The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review
por: Agrati, Chiara, et al.
Publicado: (2021)

The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies
por: Ghanbari, Emily Parissa, et al.
Publicado: (2023)

Understanding COVID-19-associated coagulopathy
por: Conway, Edward M., et al.
Publicado: (2022)

COVID-19 and Coagulopathy
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

Coagulopathy and COVID-19
por: Lorini, Ferdinando Luca, et al.
Publicado: (2021)

Coagulopathy in COVID-19
por: Lio, Ka U, et al.
Publicado: (2021)

Evaluation of the TEG(® )platelet mapping™ assay in blood donors
por: Bochsen, Louise, et al.
Publicado: (2007)

TEG(®) and ROTEM(®) in trauma: similar test but different results?
por: Sankarankutty, Ajith, et al.
Publicado: (2012)

COVID-19 update: Covid-19-associated coagulopathy
por: Becker, Richard C.
Publicado: (2020)

Thrombosis and coagulopathy in COVID‐19: An illustrated review
por: Levi, Marcel, et al.
Publicado: (2020)

COVID-19-associated coagulopathy and acute kidney injury in critically ill patients
por: da Silva, Bruno Caldin, et al.
Publicado: (2023)

COVID-19 Associated Coagulopathy and Thrombotic Complications
por: Mezalek, Zoubida Tazi, et al.
Publicado: (2020)

COVID–19-associated coagulopathy: An exploration of mechanisms
por: Colling, Meaghan E, et al.
Publicado: (2020)

Proposal of the Definition for COVID-19-Associated Coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2021)

Comparison of the coagulopathies associated with COVID‐19 and sepsis
por: Campbell, Robert A., et al.
Publicado: (2021)

COVID-19 associated coagulopathy and thrombosis in cancer
por: Levi, Marcel, et al.
Publicado: (2022)

Tissue factor in COVID-19-associated coagulopathy
por: Subramaniam, Saravanan, et al.
Publicado: (2022)

Common Coagulopathies Associated With COVID-19 Patients
por: Gupta, Vinish, et al.
Publicado: (2023)

The Diagnostic Efficacy of Thrombelastography (TEG) in Patients with Preeclampsia and its Association with Blood Coagulation
por: Lidan, He, et al.
Publicado: (2019)

Thrombosis and Coagulopathy in COVID-19
por: Gómez-Mesa, Juan Esteban, et al.
Publicado: (2021)

Reply to: COVID-19 and Coagulopathy
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Studying the coagulopathy of COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2022)

COVID-19 associated coagulopathy: Mechanisms and host-directed treatment
por: Plášek, Jiří, et al.
Publicado: (2022)

TEG in the monitoring of coagulation changes in patients with sepsis and the clinical significance
por: Zhou, Wenyan, et al.
Publicado: (2019)

Diagnostic Value of Thromboelastography (TEG) for the Diagnosis of Death in Infected Patients
por: Xuan, Jingchao, et al.
Publicado: (2021)

COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy
por: Chatterjee, Sabyasachi, et al.
Publicado: (2020)

Role of vitamin D in treating COVID-19-associated coagulopathy: problems and perspectives
por: Sengupta, Tanusree, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7n4dq4l2atq67me8p8ete22q6j